Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Testing effectiveness (Phase 2)UnknownNCT05830097
What this trial is testing

Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Who this might be right for
Cancer, BreastCancer, LungCancer of Pancreas+2 more
Coherent Biopharma (Hefei) Co., Ltd. 260
Not applicableStudy completedNCT04501913
What this trial is testing

Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage 0 Gastric Cancer AJCC v8+169 more
City of Hope Medical Center 22
Post-approval studies (Phase 4)Study completedNCT00637988
What this trial is testing

Barrett's Esophagus - 315 - 3 Way Cross Over

Who this might be right for
Barrett's Esophagus
AstraZeneca 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04229459
What this trial is testing

Trial of Nivolumab and Cetuximab After Chemoradiation in Esophageal Squamous Cell Carcinoma Patients.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Baruch Brenner 12
Large-scale testing (Phase 3)WithdrawnNCT02326779
What this trial is testing

Low-dose Aspirin Therapy for Esophageal Cancer

Who this might be right for
Esophageal Cancer
Zhejiang University
Testing effectiveness (Phase 2)UnknownNCT02636088
What this trial is testing

Definitive Chemoradiotherapy and Cetuximab in the Treatment of Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasm
Gabriella Alexandersson von Döbeln 51
Early research (Phase 1)Active Not RecruitingNCT06238479
What this trial is testing

LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid Tumor+11 more
Eli Lilly and Company 490
Early research (Phase 1)Not Yet RecruitingNCT07697040
What this trial is testing

Becotatug Vedotin Plus Cisplatin and Radiotherapy in LA-ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 12
Early research (Phase 1)UnknownNCT01984580
What this trial is testing

Effect of Zinc on Barrett's Metaplasia

Who this might be right for
Barrett's Metaplasia
Main Line Health 120
Early research (Phase 1)Enrolling By InvitationNCT07218003
What this trial is testing

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

Who this might be right for
Non Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more
Rondo Therapeutics 149
Not applicableUnknownNCT03804203
What this trial is testing

Short Course Radiation Therapy in Palliative Treatment of Esophageal Cancer

Who this might be right for
Esophageal CancerRadiotherapyPalliative Care
IRCCS Azienda Ospedaliero-Universitaria di Bologna 98
Not applicableLooking for participantsNCT06979869
What this trial is testing

Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Xijing Hospital 300
Testing effectiveness (Phase 2)UnknownNCT00865982
What this trial is testing

Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer

Who this might be right for
Gastric CancerEsophageal Cancer
Charite University, Berlin, Germany 50
Testing effectiveness (Phase 2)Study completedNCT02166320
What this trial is testing

Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent.

Who this might be right for
Esophageal CancerCancer of Gastro Esophageal JunctionPalliative Treatment
Karolinska University Hospital 80
Not applicableLooking for participantsNCT07638410
What this trial is testing

Prehabilitation in High-risk Oncologic Surgery

Who this might be right for
Pancreatic CancerColo-rectal CancerGastric Cancer+4 more
Fox Chase Cancer Center 180
Large-scale testing (Phase 3)Not Yet RecruitingNCT07251062
What this trial is testing

SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 737
Early research (Phase 1)UnknownNCT06205082
What this trial is testing

A Phase I Clinical Trial to Evaluate LIT-00814 Tablets in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
LittDD Medicines Ltd 81
Not applicableStudy completedNCT03743883
What this trial is testing

EffectiveNess of Low-dose Aspirin in Prevention of Cancer in the Stomach and Oesophagus (GastrointEstinal Cancer Prevention) - United Kingdom ("ENgAGE - UK"): Study to Evaluate the Risk of Cancer in the Stomach and Oesophagus Among New Users of Low-dose Aspirin Using the THIN Database in the UK

Who this might be right for
Prevention of Oesophagus Cancer and Stomach Cancer
Bayer 99,999
Testing effectiveness (Phase 2)Looking for participantsNCT07188103
What this trial is testing

Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Anhui Provincial Hospital 37
Next Page